Profilo
G.
Scott Walker is currently a Director at Pharmadelic Labs Corp., a Member of the International Cannabinoid Research Society, and a Member of the Cannabis Canada Association.
Previously, he worked as a Vice President-Corporate Development at Wildflower Brands, Inc.
Posizioni attive di G. Scott Walker
| Società | Posizione | Inizio |
|---|---|---|
Cannabis Canada Association
Cannabis Canada Association Pharmaceuticals: OtherHealth Technology Produces cannabis for medical purpose | Corporate Officer/Principal | - |
International Cannabinoid Research Society
International Cannabinoid Research Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit political and religious professional association to scientific research | Corporate Officer/Principal | - |
Pharmadelic Labs Corp.
Pharmadelic Labs Corp. Pharmaceuticals: OtherHealth Technology Improves engineering processes for the biosynthesis of compounds primarily psilocybin, the psychoactive component of magic mushrooms | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di G. Scott Walker
| Società | Posizione | Fine |
|---|---|---|
| WILDFLOWER BRANDS INC. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Wildflower Brands, Inc.
Wildflower Brands, Inc. Pharmaceuticals: OtherHealth Technology Develops and wholesales CBD and cannabis wellness products | Health Technology |
International Cannabinoid Research Society
International Cannabinoid Research Society Miscellaneous Commercial ServicesCommercial Services Operates as a non profit political and religious professional association to scientific research | Commercial Services |
Cannabis Canada Association
Cannabis Canada Association Pharmaceuticals: OtherHealth Technology Produces cannabis for medical purpose | Health Technology |
Pharmadelic Labs Corp.
Pharmadelic Labs Corp. Pharmaceuticals: OtherHealth Technology Improves engineering processes for the biosynthesis of compounds primarily psilocybin, the psychoactive component of magic mushrooms | Health Technology |
















